A carregar...
Addition of DHA synergistically enhances the efficacy of regorafenib for kidney cancer therapy
Kidney cancer is the 6(th) most common cancer in the US and its incidence is increasing. The treatment of this malignancy took a major step forward with the recent introduction of targeted therapeutics such as the kinase inhibitors. Unfortunately, kinase inhibition is associated with the onset of re...
Na minha lista:
| Publicado no: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4873345/ https://ncbi.nlm.nih.gov/pubmed/26921392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0847 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|